U.S., Dec. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07256184) titled 'Prognostic and Treatment-Response Factors in Metastatic Melanoma: Multi-Center Analysis' on Nov. 20.
Brief Summary: This multicenter retrospective observational study aims to identify clinical, pathological, and molecular factors that influence prognosis and treatment response in patients with metastatic malignant melanoma.
Medical records of adult patients diagnosed and treated for metastatic melanoma between November 2022 and December 2024 at participating oncology centers in Turkiye will be reviewed.
Demographic characteristics, disease stage, histopathologic features, treatment modalities (immunotherapy, targeted therapy, chemo...